ClinicalTrials.govpublic full text
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
gaucher disease, acid beta-glucocerebrosidase, human, glucocerebrosidase, enzyme replacement therapy, d-glucosyl-n-acylsphingosine glucohydrolase, glucosylceramidase, gene activation, beta-glucocerebrosidase, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 906113
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.